Search Within

Michael Andrew Postow

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (48)
  2. Meeting Abstract (34)
  3. Research Letter (2)
Groups
  1. Department of Medicine (84)
  2. Epidemiology and Biostatistics (84)
  3. Melanoma Disease Management Team (84)
  4. Melanoma and Immunotherapeutics Service (84)
  5. Solid Tumor Oncology Division (84)
  6. Biostatistics Service (78)

More Groups

People
  1. Katherine Panageas (64)
  2. Jedd Wolchok (48)
  3. Alexander Shoushtari (40)
  4. Margaret Callahan (37)
  5. Paul Chapman (34)
  6. Parisa Momtaz (28)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Annals of Surgical Oncology (5)
  3. Journal for ImmunoTherapy of Cancer (5)
  4. The Oncologist (5)
  5. Clinical Cancer Research (4)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (6)
  4. Biomed Central Ltd (5)
  5. Nature Publishing Group (5)
  6. Springer (5)

More Publishers

Results (84)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
    Journal Article

    Postow, M. A.; Chasalow, S. D.; Kuk, D.; Panageas, K. S.; Cheng, M. L.; Yuan, J.; Wolchok, J. D.
    Melanoma Research (2020)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Shoushtari, A. N.; Armenia, J.; Arora, A.; Rojas-Zamalloa, J.; Warner, A. B.; Derr, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Coit, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
    Meeting Abstract

    Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save